Allelic methylation levels of the noncoding VTRNA2-1 located on chromosome 5q31.1 predict outcome in AML (scientific article published on 4 November 2011)

Sensitive Melting Analysis after Real Time- Methylation Specific PCR (SMART-MSP): high-throughput and probe-free quantitative DNA methylation detection

Q24646396

Identification of a hierarchy of multipotent hematopoietic progenitors in human cord blood

Q24656265

DNMT3A Mutations in Acute Myeloid Leukemia

Q27559610

Acquired mutations in the genes encoding IDH1 and IDH2 both are recurrent aberrations in acute myeloid leukemia: prevalence and prognostic value

Q27851569

Human mortalin (HSPA9): a candidate for the myeloid leukemia tumor suppressor gene on 5q31

Q28200238

Epstein-barr virus-induced expression of a novel human vault RNA

Q28238627

The non-coding RNA of the multidrug resistance-linked vault particle encodes multiple regulatory small RNAs

Q28258414

Haploinsufficiency of Apc leads to ineffective hematopoiesis

Q42198272

Progressive chromatin repression and promoter methylation of CTNNA1 associated with advanced myeloid malignancies.

Q42721337

Nuclear factor-kappaB is constitutively activated in primitive human acute myelogenous leukemia cells

Q43757315

Profiling DNA methylation by melting analysis

Q44048650

A role for PKR in hematologic malignancies.

Q46035657

Identification of patients with acute myeloblastic leukemia who benefit from the addition of gemtuzumab ozogamicin: results of the MRC AML15 trial.

Q53446336

RIL, a LIM gene on 5q31, is silenced by methylation in cancer and sensitizes cancer cells to apoptosis.

Q55043439

Impact of adjunct cytogenetic abnormalities for prognostic stratification in patients with myelodysplastic syndrome and deletion 5q

Q58010138

Narrowing and genomic annotation of the commonly deleted region of the 5q- syndrome

Q63248769

HL-60 cell line was derived from a patient with FAB-M2 and not FAB-M3

Q68518557

Allele-specific methylation of the human c-Ha-ras-1 gene

Q69001647

Delineation of a minimal interval and identification of 9 candidates for a tumor suppressor gene in malignant myeloid disorders on 5q31

Q73584833

The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties

Q28283156

Vaults and the major vault protein: novel roles in signal pathway regulation and immunity

Q28292504

The dsRNA protein kinase PKR: virus and cell control

Q28298945

Integrative analysis of the Caenorhabditis elegans genome by the modENCODE project

Q28301622

Equitoxic doses of 5-azacytidine and 5-aza-2'deoxycytidine induce diverse immediate and overlapping heritable changes in the transcriptome

Q28475641

Haploinsufficiency of EGR1, a candidate gene in the del(5q), leads to the development of myeloid disorders

Q33374851

Quantitative DNA methylation predicts survival in adult acute myeloid leukemia

Q33515724

Non-imprinted allele-specific DNA methylation on human autosomes.

Q33616901

Inhibition of RNA-dependent protein kinase (PKR) leads to cancer cell death and increases chemosensitivity

Q33787696

Ribosomopathies: human disorders of ribosome dysfunction

Q33806050

Prospective isolation of human clonogenic common myeloid progenitors

Q34154606

MiR-886-3p down regulates CXCL12 (SDF1) expression in human marrow stromal cells

Q34403683

Identification of miR-145 and miR-146a as mediators of the 5q- syndrome phenotype

Q35011883

Clinical effect of increasing doses of lenalidomide in high-risk myelodysplastic syndrome and acute myeloid leukemia with chromosome 5 abnormalities

Q35082495

Lenalidomide inhibits the malignant clone and up-regulates the SPARC gene mapping to the commonly deleted region in 5q- syndrome patients

Q35844148

Telomere maintenance and human bone marrow failure

Q36591289

Multiple forms of PKR present in the nuclei of acute leukemia cells represent an active kinase that is responsive to stress.

Q39632814

MicroRNA miR-886-5p inhibits apoptosis by down-regulating Bax expression in human cervical carcinoma cells

Q39644070

The DNA demethylating agent 5-aza-2'-deoxycytidine induces expression of NY-ESO-1 and other cancer/testis antigens in myeloid leukemia cells

Q39716492

PKR activity is required for acute leukemic cell maintenance and growth: a role for PKR-mediated phosphatase activity to regulate GSK-3 phosphorylation

Q39841023

Evolution of vault RNAs.

Q39843577

Chromosome 5q deletion and epigenetic suppression of the gene encoding alpha-catenin (CTNNA1) in myeloid cell transformation

Q40198158

Evaluation of ETF1/eRF1, mapping to 5q31, as a candidate myeloid tumor suppressor gene

Q40733689

Defining the RNA polymerase III transcriptome: Genome-wide localization of the RNA polymerase III transcription machinery in human cells

Q40784094

P433

issue

P407

language of work or name

English

Q1860

P304

page(s)

206-216

P577

publication date

2011-11-04

P1433

published in

Blood

Q885070

P1476

title

Allelic methylation levels of the noncoding VTRNA2-1 located on chromosome 5q31.1 predict outcome in AML

P478

volume

119

Reverse relations

cites work (P2860)

Q89763099	'High vault-age': non-coding RNA control of autophagy
Q26801690	A Novel Type of Non-coding RNA, nc886, Implicated in Tumor Sensing and Suppression
Q90737222	A Regulatory Noncoding RNA, nc886, Suppresses Esophageal Cancer by Inhibiting the AKT Pathway and Cell Cycle Progression
Q35123099	A microRNA signature predicts survival in early stage small-cell lung cancer treated with surgery and adjuvant chemotherapy
Q36396528	A tumor surveillance model: a non-coding RNA senses neoplastic cells and its protein partner signals cell death
Q48242097	A unique methylation pattern co-segregates with neural tube defect statuses in Han Chinese pedigrees
Q37407462	Cell death/proliferation roles for nc886, a non-coding RNA, in the protein kinase R pathway in cholangiocarcinoma
Q45075215	Characterization of the direct physical interaction of nc886, a cellular non-coding RNA, and PKR.
Q34979379	Comparative anatomy of chromosomal domains with imprinted and non-imprinted allele-specific DNA methylation
Q47879788	DNA methylation in blood from neonatal screening cards and the association with BMI and insulin sensitivity in early childhood
Q36081115	DNA methylation patterns in naïve CD4+ T cells identify epigenetic susceptibility loci for malar rash and discoid rash in systemic lupus erythematosus
Q54986273	Deoxyribonucleic Acid Methylation in Systemic Lupus Erythematosus: Implications for Future Clinical Practice.
Q100693919	Detection of haplotype-dependent allele-specific DNA methylation in WGBS data
Q39338976	Epigenetic regulation of RNA polymerase III transcription in early breast tumorigenesis
Q39098728	Epigenetic regulation of noncoding RNA transcription by mammalian RNA polymerase III.
Q33976897	Epigenetic silencing of the non-coding RNA nc886 provokes oncogenes during human esophageal tumorigenesis
Q47196130	Epigenetic supersimilarity of monozygotic twin pairs
Q34671934	Epigenetic upregulation of lncRNAs at 13q14.3 in leukemia is linked to the In Cis downregulation of a gene cluster that targets NF-kB.
Q40378767	Human noncoding RNA 886 (nc886) adopts two structurally distinct conformers that are functionally opposing regulators of PKR.
Q36401117	Hypermethylation of the VTRNA1-3 Promoter is Associated with Poor Outcome in Lower Risk Myelodysplastic Syndrome Patients
Q35730128	Independent genomewide screens identify the tumor suppressor VTRNA2-1 as a human epiallele responsive to periconceptional environment
Q57804799	Insights into imprinting from parent-of-origin phased methylomes and transcriptomes
Q37201885	Investigation of MGMT and DAPK1 methylation patterns in diffuse large B-cell lymphoma using allelic MSP-pyrosequencing
Q37139037	Long non-coding RNAs in haematological malignancies.
Q46191604	Long noncoding RNAs in hematopoietic malignancies
Q64078118	Mechanism mediated by a noncoding RNA, nc886, in the cytotoxicity of a DNA-reactive compound
Q60309440	Mother-child transmission of epigenetic information by tunable polymorphic imprinting
Q48261248	Nc886 is epigenetically repressed in prostate cancer and acts as a tumor suppressor through the inhibition of cell growth.
Q37591537	Non-coding RNAs as direct and indirect modulators of epigenetic regulation
Q40991874	Novel aberrant genetic and epigenetic events in Friedreich's ataxia
Q37630734	Nucleosome Positioning and NDR Structure at RNA Polymerase III Promoters
Q49832286	Occupational exposure to pesticides is associated with differential DNA methylation.
Q57929266	Prenatal arsenic exposure is associated with increased plasma IGFBP3 concentrations in 9-year-old children partly via changes in DNA methylation
Q46513323	Prenatal phthalate exposure and altered patterns of DNA methylation in cord blood.
Q38183943	Prognostic factors for acute myeloid leukaemia in adults--biological significance and clinical use.
Q36414061	Regulation of p53 expression and apoptosis by vault RNA2-1-5p in cervical cancer cells
Q38609324	Reprogramming of the human intestinal epigenome by surgical tissue transposition
Q64284722	Role of microRNAs, circRNAs and long noncoding RNAs in acute myeloid leukemia
Q39406956	Specific Depletion of Leukemic Stem Cells: Can MicroRNAs Make the Difference?
Q52966734	The Role of DNA Methylation in Cancer.
Q38198569	The use of molecular genetics to refine prognosis in acute myeloid leukemia
Q28071427	Therapeutic Resistance in Acute Myeloid Leukemia: The Role of Non-Coding RNAs
Q36838971	Tissue-specific patterns of allelically-skewed DNA methylation
Q40917151	Tobacco smoking-associated genome-wide DNA methylation changes in the EPIC study
Q89657713	Uncovering Tumour Heterogeneity through PKR and nc886 Analysis in Metastatic Colon Cancer Patients Treated with 5-FU-Based Chemotherapy
Q33779206	Variable maternal methylation overlapping the nc886/vtRNA2-1 locus is locked between hypermethylated repeats and is frequently altered in cancer.
Q36562094	Whole-exome sequencing and genome-wide methylation analyses identify novel disease associated mutations and methylation patterns in idiopathic hypereosinophilic syndrome
Q64290120	ZCCHC10 suppresses lung cancer progression and cisplatin resistance by attenuating MDM2-mediated p53 ubiquitination and degradation
Q38987143	c-Myc suppresses microRNA-29b to promote tumor aggressiveness and poor outcomes in non-small cell lung cancer by targeting FHIT.
Q51760786	nc886 is induced by TGF-β and suppresses the microRNA pathway in ovarian cancer.
Q37688884	nc886, a non-coding RNA and suppressor of PKR, exerts an oncogenic function in thyroid cancer
Q33977148	nc886, a non-coding RNA of anti-proliferative role, is suppressed by CpG DNA methylation in human gastric cancer
Q89861842	vtRNA2-1/nc886 Produces a Small RNA That Contributes to Its Tumor Suppression Action through the microRNA Pathway in Prostate Cancer